Tildelt2026-114934· Sendt til TED
Development services for minimally invasive glaucoma surgery (MIGS) device
Beskrivelse fra kunngjøringen
We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion.
The development scope, estimated to about 2 years of development, includes optimizing the stent design using in silico modeling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection molding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.
Tildelingskriterier
Slik vektes tilbudene i konkurransen (vekt i prosent).
- Quality of Technical Solution · Kvalitet40 %
- Project Management and Delivery Capability · Kvalitet20 %
- Price · Pris40 %
Kontraktsdetaljer
Development services for minimally invasive glaucoma surgery (MIGS) device5 år · opptil 1 fornyelser · 1 tilbud
- VinnerFearsome Ltd3,00 mill kr · kontrakt 18.9.2026
Parter
Kjøper
- Inven2 AS995495899
Vinner
- Fearsome Ltd
Rådgivere og øvrige parter
- Oslo tingrett926725939
- Artifik AS925364967
Full kunngjøring
Kjøper
Prosedyre
Beskrivelse
We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion. The development scope, estimated to about 2 years of development, includes optimizing the stent design using in silico modeling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection molding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.
Hensikt
Ytterligere klassifisering
- Medisinsk utstyr, legemidler og utstyr til personlig pleie
- Oftalmologiutstyr
Sted for gjennomføring
Verdi
Generell informasjon
Delkontrakt
Beskrivelse
We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion. The development scope, estimated to about 2 years of development, includes optimizing the stent design using in silico modeling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection molding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.
Hensikt
Ytterligere klassifisering
- Medisinsk utstyr, legemidler og utstyr til personlig pleie
- Oftalmologiutstyr
Sted for gjennomføring
Anslått varighet
Fornyelse
Beskrivelse
3 år. The contract may be extended by another 3 years, pending the availability of development funding. While the present contract seeks to develop a device that can be tested in vivo (prototype), the option refers to development of a device suitable for clinical testing. This entails the use of clinical-grade materials, risk planning, and regulatory development as well as preparation of the clinical trial. We foresee the delivery of clinical-grade stents in batches of 30-100. The option may be called within 3 years following the completion of the initial project.
Generell informasjon
Tildelingskriterier
Kriterium
Category of award threshold criterionVekt (prosent, presis)
Kriterium
Category of award threshold criterionVekt (prosent, presis)
Kriterium
Category of award threshold criterionVekt (prosent, presis)
Teknikker
Rammeavtale
Informasjon om den dynamiske innkjøpsordningen
Nærmere informasjon, mekling og revisjon
Resultater
Direkte tildeling
Begrunnelse for direkte tildeling
Kun irregulære eller uakseptable anbud ble mottatt som svar på et tidligere varsel. Alle og bare de tilbydere av den forrige prosedyren som har oppfylt utvelgingskriteriene, ikke har oppfylt eksklusjonsgrunnene og har oppfylt formelle krav, ble inkludert i forhandlingene
Annen begrunnelse
In the original tender, the two qualified providers did not fully comply with the requirements, one delivering after the deadline and one neglecting to include subproviders.
Identifikator for resultatpartiLOT-0001
Informasjon om vinnere
Vinner
Informasjon om kontrakt
Statistisk informasjon
Mottatte tilbud eller forespørsler om å delta
Type mottatte innleveringerTilbud er levert elektronisk
Virksomheter
Rollene til denne virksomheten
Kunngjøringsinformasjon
Andre anbud fra INVEN2 AS
Lignende anbud
Veiledende kunngjøring: Markedsutprøving av Fakomaskin i forkant av konkurranse
Medical Technology Device Design
3,30 mill kr
endoskopisk terapi
800 000 kr
Portabel digital røntgenmaskin og hyperspectral camera
Trinn 1 Kvalifikasjonsfase: Lungefunksjonsutstyr til Universitetssykehuset Nord-Norge HF